Edition:
United Kingdom

People: Allergan plc (AGN.N)

AGN.N on New York Stock Exchange

163.16USD
19 Jul 2019
Change (% chg)

$1.11 (+0.68%)
Prev Close
$162.05
Open
$162.46
Day's High
$163.18
Day's Low
$161.01
Volume
493,468
Avg. Vol
679,414
52-wk High
$197.00
52-wk Low
$114.27

D'Arecca, James 

Mr. James C. D'Arecca is Chief Accounting Officer of Allergan Plc. Mr. D’Arecca is the Chief Accounting Officer of Allergan, and has served in this role since August 2013. Prior to joining Allergan (then known as Actavis), he held a similar position at Bausch + Lomb. Prior to joining Bausch + Lomb, Mr. D’Arecca worked for Merck & Co. and Schering-Plough. He also spent 13 years with PricewaterhouseCoopers as a Certified Public Accountant. Mr. D’Arecca received his MBA from Columbia University and his B.S. in Accounting from Rutgers University.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Award, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --